Healthy high growth potential

Results

90

2 new

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

90 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
1729
HK$15.93-11.6%165.1%HK$35.5bHK$25.0045.433.6%0.3%Capital Goods
2480
HK$12.35-8.5%-46.1%HK$2.5bHK$31.003.277.1%n/aPharmaceuticals & Biotech
3881
HK$18.32-16.7%n/aHK$8.0bn/a7.8107.6%n/aCapital Goods
1357
HK$4.64-7.6%-40.3%HK$21.1bHK$9.3524.931.5%2.2%Media
1860
HK$13.83-0.6%80.3%HK$21.2bHK$18.2636.441.1%n/aMedia
325
HK$54.357.2%-68.6%HK$13.5bHK$81.0018.422.7%n/aConsumer Durables
2315
HK$38.54-7.8%73.2%HK$38.9bHK$62.0251.240.4%n/aPharmaceuticals & Biotech
2171
HK$15.02-8.0%-35.5%HK$8.9bHK$21.2261.382.1%n/aPharmaceuticals & Biotech
6990
HK$415.205.5%19.7%HK$96.8bHK$547.6440.644.8%n/aPharmaceuticals & Biotech
2408
HK$3.73-14.3%n/aHK$2.6bHK$8.0022.154.3%0.9%Consumer Services
340
HK$1.82-8.5%-31.8%HK$9.7bHK$4.3911.631.1%1.8%Materials
9863
HK$38.82-6.0%-28.1%HK$55.2bHK$69.5888.539.4%n/aAutomobiles
9936
HK$14.85-14.9%282.7%HK$5.6bHK$25.2128.439.4%0.4%Materials
2556
New
HK$37.3011.7%-11.1%HK$10.0bHK$59.3596.957.6%n/aSoftware
2591
HK$8.38-16.2%n/aHK$3.8bHK$31.5925.195.4%n/aPharmaceuticals & Biotech
6656
HK$379.60-9.7%n/aHK$93.7bHK$656.1127.732.6%n/aCapital Goods
2657
HK$33.50-8.5%n/aHK$4.7bHK$112.9511.426.4%3.3%Household
1318
HK$62.10-2.7%-44.2%HK$30.4bHK$106.1821.821.3%1.9%Household
1415
HK$25.02-12.6%3.8%HK$21.7bHK$41.3814.123.1%1.3%Tech
3858
HK$88.701.4%n/aHK$40.4bHK$158.30132.559.6%n/aMaterials
631
HK$7.33-3.0%9.2%HK$24.1bHK$14.1312.631.7%4.8%Capital Goods
1050
HK$2.92-7.9%265.0%HK$6.1bHK$3.8929.943.6%1.5%Tech
9926
HK$92.00-1.7%-4.0%HK$84.7bHK$172.1723.961.0%n/aPharmaceuticals & Biotech
2420
HK$3.750%10.9%HK$1.9bHK$6.786.022.7%6.1%Retail
Page 1 of 3